| Congenital Heart Disease in Adults |
| 47 |
Assessment of anomalies of coronary arterial and other thoracic vasculatures |
A (9) |
A |
(179, 183, 187) |
| 48 |
Assessment of complex adult congenital heart disease |
A (9) |
A |
(193, 198, 199) |
| Evaluation of Ventricular Structure and Systolic Function |
| 49 |
Initial evaluation of left ventricular (LV) function, following acute MI or in HF patients |
U (4) |
C |
NA |
| 50 |
Evaluation of LV function, following acute MI or in HF patients, inadequate images from other noninvasive methods |
A (7) |
A |
(203, 205) |
| 51 |
Quantitative evaluation of right ventricular (RV) function |
A (7) |
A |
(211, 212, 213) |
| 52 |
Assessment of RV morphology, suspected arrhythmogenic RV dysplasia |
A (7) |
A |
(214, 215) |
| 53 |
Assessment of myocardial viability, prior to myocardial revascularization for ischemic LV systolic dysfunction, other imaging modalities are inadequate or contraindicated |
U (5) |
B |
(217, 218, 219) |
| 54 |
To determine the location and extent of myocardial infarction including 'no-reflow' regions, post-acute MI |
U (6) |
C |
(221) |
| 55 |
Serving as an 'one-stop shop' for ischemic heart disease in diagnosis, comprehensive evaluation and treatment strategy planning in difficult cases |
A (8) |
C |
(222) |
| Evaluation of Intra- and Extracardiac Structures |
| 56 |
Characterization of native cardiac valves, suspected clinically significant valvular dysfunction, inadequate images from other noninvasive methods |
A (8) |
A |
(225, 228) |
| 57 |
Characterization of prosthetic cardiac valves, suspected clinically significant valvular dysfunction, inadequate images from other noninvasive methods |
A (8) |
A |
(228, 237, 238, 239) |
| 58 |
Initial evaluation of cardiac mass (suspected tumor or thrombus) |
U (4) |
C |
NA |
| 59 |
Evaluation of cardiac mass (suspected tumor or thrombus), inadequate images from other noninvasive methods |
A (8) |
A |
(243, 244) |
| 60 |
Evaluation of pericardial anatomy |
A (8) |
A |
(246, 248) |
| 61 |
Evaluation of pulmonary vein anatomy, prior to radiofrequency ablation for atrial fibrillation |
A (8) |
A |
(252) |
| 62 |
Noninvasive coronary vein mapping, prior to placement of biventricular pacemaker |
A (8) |
A |
(253, 254, 255) |
| 63 |
Localization of coronary bypass grafts and other retrosternal anatomy, prior to reoperative chest or cardiac surgery |
A (8) |
A |
(258, 259) |
| 64 |
Anatomic assessment before percutaneous device closure of ASD or VSD or percutaneous aortic valve replacement |
A (8) |
B |
(231, 232, 233, 260) |
| Morphologic Study of Congenital Heart Disease |
| 65 |
Assessment of complex congenital heart disease including anomalies of coronary circulation, great vessels, and cardiac chambers and valves |
A (8) |
B |
(261, 263, 266) |
| 66 |
Assessment of post-operative congenital heart disease, such as residual pulmonary stenosis, ventricular septal defect and patency check for Blalock-Taussig shunt |
A (8) |
C |
(199) |
| Coronary CT Angiography in Kawasaki Disease Patients |
| 67 |
Asymptomatic, no previous definite test (invasive angiography, MRCA or coronary CT angiography) available |
U (5) |
C |
NA |
| 68 |
Asymptomatic, previous tests (invasive angiography, CMR or coronary CT angiography) documented coronary aneurysm/ stenosis, for follow up |
A (7) |
C |
(276, 277) |
| 69 |
Symptomatic, no previous definite test available |
A (7) |
C |
NA |
| 70 |
Symptomatic, previous tests (angiography, CMR or coronary CT angiography) documented coronary aneurysm/stenosis, for follow up |
A (8) |
C |
(276, 277) |
